Novamin on Streptococcus Mutans Count in Dental Plaque of High Caries Risk Children

NCT ID: NCT05979636

Last Updated: 2023-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-06

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inhibition of streptococcus mutans can be effective to prevent caries in high caries-risk children. The aim of the study is to evaluate the effect of Novamin on streptococcus mutans in the plaque of high caries-risk children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Plaque Dental Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test group

Group Type EXPERIMENTAL

Novamin containing toothpaste

Intervention Type OTHER

children's teeth will be brushed using Novamin containing toothpaste.

Control group

Group Type ACTIVE_COMPARATOR

Fluoride containing toothpaste

Intervention Type OTHER

children's teeth will be brushed using Fluoride containing toothpaste.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Novamin containing toothpaste

children's teeth will be brushed using Novamin containing toothpaste.

Intervention Type OTHER

Fluoride containing toothpaste

children's teeth will be brushed using Fluoride containing toothpaste.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medically healthy children.
* No erupting first permanent molars.
* High caries risk children; Have visible cavities or have a visible plaque on their teeth.
* Cooperative (Positive or definitely positive), according to Frankl's Behavior Rating Scale

Exclusion Criteria

* History of intake of antibiotics for the past 3-4 weeks.
* History of professional fluoride treatment over 2 weeks before the study.
* Children with tooth structure defects.
* Children unable to return for recall visits
Minimum Eligible Age

3 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hams Hamed Abdelrahman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alexandria Faculty of Dentistry

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0286-09/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anti-gingivitis Mouthrinse
NCT06048627 COMPLETED PHASE3